← SynDRA
ML-179
SynDRA canonical compound SYN0062939 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | NR5A2 |
|---|
| Mechanism of action | liver receptor homolog inverse agonist |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- ML179
- ML 179
- -1H-pyrimidine-2,4-dione
- MLS003153122
- methyl)phenyl]piperazin-1-yl]
- orb1685339
- SCHEMBL31047995
- SCHEMBL31314290
- CHEBI:93361
- MFABFKUNLDYKGH-UHFFFAOYSA-N
- EX-A4951
- 3-Cyclohexyl-6-[4-[3-(trifluoro
- BDBM50417872
- AKOS025147320
- ML-179?
- NCGC00370713-04
- NCGC00370713-05
- AC-36928
- MS-27414
- SMR001857786
- HY-110329
- CS-0033249
- G79285
- SR-03000001309
- SR-03000001309-1
- 3-cyclohexyl-6-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]-1H-pyrimidine-2,4-dione
Look up ML-179 in the interactive SynDRA portal →